BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38278074)

  • 1. Transplacental transport of per- and polyfluoroalkyl substances (PFAS): Mechanism exploration via BeWo cell monolayer model.
    Chen H; Wei S; Li J; Zhong Z; Chen D
    J Hazard Mater; 2024 Mar; 466():133205. PubMed ID: 38278074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiles and transplacental transfer of per- and polyfluoroalkyl substances in maternal and umbilical cord blood: A birth cohort study in Zhoushan, Zhejiang Province, China.
    Liu L; Yan P; Liu X; Zhao J; Tian M; Huang Q; Yan J; Tong Z; Zhang Y; Zhang J; Zhang T; Guo J; Liu G; Bian X; Li B; Wang T; Wang H; Shen H
    J Hazard Mater; 2024 Mar; 466():133501. PubMed ID: 38246060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Per- and polyfluoroalkyl substances (PFAS) exposure in women seeking in vitro fertilization-embryo transfer treatment (IVF-ET) in China: Blood-follicular transfer and associations with IVF-ET outcomes.
    Hong A; Zhuang L; Cui W; Lu Q; Yang P; Su S; Wang B; Zhang G; Chen D
    Sci Total Environ; 2022 Sep; 838(Pt 3):156323. PubMed ID: 35636536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplacental Transfer of Per- and Polyfluoroalkyl Substances (PFASs): Differences between Preterm and Full-Term Deliveries and Associations with Placental Transporter mRNA Expression.
    Li J; Cai D; Chu C; Li Q; Zhou Y; Hu L; Yang B; Dong G; Zeng X; Chen D
    Environ Sci Technol; 2020 Apr; 54(8):5062-5070. PubMed ID: 32208722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse birth outcomes related to concentrations of per- and polyfluoroalkyl substances (PFAS) in maternal blood collected from pregnant women in 1960-1966.
    Zheng T; Kelsey K; Zhu C; Pennell KD; Yao Q; Manz KE; Zheng YF; Braun JM; Liu Y; Papandonatos G; Liu Q; Shi K; Brochman S; Buka SL
    Environ Res; 2024 Jan; 241():117010. PubMed ID: 37696323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of perfluoroalkyl substances with adipocytokines in umbilical cord serum: A mixtures approach.
    Ding J; Dai Y; Zhang J; Wang Z; Zhang L; Xu S; Tan R; Guo J; Qi X; Chang X; Wu C; Zhou Z
    Environ Res; 2023 Jan; 216(Pt 3):114654. PubMed ID: 36309220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine exposure to per- and polyfluoroalkyl substances may harm children's lung function development.
    Kung YP; Lin CC; Chen MH; Tsai MS; Hsieh WS; Chen PC
    Environ Res; 2021 Jan; 192():110178. PubMed ID: 32991923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum per- and polyfluoroalkyl substances and abnormal lipid metabolism: A nationally representative cross-sectional study.
    Wu B; Pan Y; Li Z; Wang J; Ji S; Zhao F; Chang X; Qu Y; Zhu Y; Xie L; Li Y; Zhang Z; Song H; Hu X; Qiu Y; Zheng X; Zhang W; Yang Y; Gu H; Li F; Cai J; Zhu Y; Cao Z; S Ji J; Lv Y; Dai J; Shi X
    Environ Int; 2023 Feb; 172():107779. PubMed ID: 36746113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nontargeted identification of per- and polyfluoroalkyl substances in human follicular fluid and their blood-follicle transfer.
    Kang Q; Gao F; Zhang X; Wang L; Liu J; Fu M; Zhang S; Wan Y; Shen H; Hu J
    Environ Int; 2020 Jun; 139():105686. PubMed ID: 32278886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A State-of-the-Science Review of Interactions of Per- and Polyfluoroalkyl Substances (PFAS) with Renal Transporters in Health and Disease: Implications for Population Variability in PFAS Toxicokinetics.
    Niu S; Cao Y; Chen R; Bedi M; Sanders AP; Ducatman A; Ng C
    Environ Health Perspect; 2023 Jul; 131(7):76002. PubMed ID: 37418334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental Exposure to Emerging Alternatives of Per- and Polyfluoroalkyl Substances and Polycystic Ovarian Syndrome in Women Diagnosed with Infertility: A Mixture Analysis.
    Zhan W; Qiu W; Ao Y; Zhou W; Sun Y; Zhao H; Zhang J
    Environ Health Perspect; 2023 May; 131(5):57001. PubMed ID: 37134253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early menarche and other endocrine disrupting effects of per- and polyfluoroalkyl substances (PFAS) in adolescents from Northern Norway. The Fit Futures study.
    Averina M; Huber S; Almås B; Brox J; Jacobsen BK; Furberg AS; Grimnes G
    Environ Res; 2024 Feb; 242():117703. PubMed ID: 37984785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
    Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of serum-dependent impacts on intracellular accumulation and genomic response of per- and polyfluoroalkyl substances in a placental trophoblast model.
    Bangma J; Szilagyi J; Blake BE; Plazas C; Kepper S; Fenton SE; C Fry R
    Environ Toxicol; 2020 Dec; 35(12):1395-1405. PubMed ID: 32790152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the cytotoxicity of per- and polyfluoroalkyl substances in HepG2 cells: A structure-activity relationship approach.
    Amstutz VH; Cengo A; Gehres F; Sijm DTHM; Vrolijk MF
    Toxicology; 2022 Oct; 480():153312. PubMed ID: 36075290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on toxicologically relevant gene expression profiles in a liver-on-a-chip model.
    Solan ME; Schackmuth B; Bruce ED; Pradhan S; Sayes CM; Lavado R
    Environ Pollut; 2023 Nov; 337():122610. PubMed ID: 37742859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of per- and polyfluoroalkyl substances (PFAS) in human placental tissues and associations with birth outcomes.
    Hall SM; Zhang S; Hoffman K; Miranda ML; Stapleton HM
    Chemosphere; 2022 May; 295():133873. PubMed ID: 35143854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of perfluoroalkyl and polyfluoroalkyl substances with gestational hypertension and blood pressure during pregnancy: A cohort study.
    Yang L; Ji H; Liang H; Yuan W; Song X; Li X; Niu J; Shi H; Wen S; Miao M
    Environ Res; 2022 Dec; 215(Pt 2):114284. PubMed ID: 36088993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.